COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,281 Articles (22,759 medRxiv, 8,522 bioRxiv)

Most recent first Previous |  Page 431: Articles 4301-4310  | Next

Receipt of anti-SARS-CoV-2 pharmacotherapies among non-hospitalized U.S. Veterans with COVID-19, January 2022 to January 2023
Yan, L., Streja, E., Li, Y., Rajeevan, N., Rowneki, M., Berry, K., Hynes, D. M., Cunningham, F., Huang, G. D., Aslan, M., Ioannou, G. N., Bajema, K. L.
10.1101/2023.05.03.23289479 — Posted: 2023-05-05
Excess Mortality Resulting from COVID-19 in Turkey during 2020-2021: Regional and Time-Based Analysis
Keskin, S., Ergor, G.
10.1101/2023.05.04.23289498 — Posted: 2023-05-05
The plasma metabolome of long COVID-19 patients two years after infection
Lopez-Hernandez, Y., Monarrez-Aquino, J., Garcia-Lopez, D. A., Zheng, J., Borrego, J. C., Torres-Calzada, C., Elizalde-Diaz, J. P., Mandal, R., Berjanskii, M., Martinez-Martinez, E., Lopez, J. A., Wishart, D. S.
10.1101/2023.05.03.23289456 — Posted: 2023-05-05
COVID-19 Infection Is Associated with Poor Outcomes in Patients with Intracerebral Hemorrhage
Renedo, D. B., Leasure, A. C., Young, R., Rivier, C., Alhanti, B., Mac Grory, B., Messe, S. R., Reeves, M. J., Hassan, A. E., Schwamm, L. H., de Havenon, A., Matouk, C. C., Sheth, K. N., Falcone, G. J.
10.1101/2023.05.03.23289488 — Posted: 2023-05-05
COVID-19 vaccination at a hospital in Paris: spatial analyses and inverse equity hypothesis
Ridde, V., Andre, G., Bouchaud, O., Bonnet, E.
10.1101/2023.05.05.23289561 — Posted: 2023-05-05
Primary series and booster COVID-19 vaccine effectiveness in a cohort of healthcare workers in Albania during a BA.1 and BA.2 variant period, January - May 2022
Finci, I., Rojas Castro, M. Y., Hasibra, I., Sulo, J., Fico, A., Daja, R., Vasili, A., Kota, M., Preza, I., Muehlemann, B., Drosten, C., Pebody, R., Lafond, K. E., Kissling, E., Katz, M. A., Bino, S.
10.1101/2023.05.05.23289503 — Posted: 2023-05-05
Paired associated SARS-CoV-2 spike variable positions: a network analysis approach to emerging variants
Manoussopoulos, Y., Anastassopoulou, C., Ioannidis, J., Tsakris, A.
10.1101/2023.05.04.539462 — Posted: 2023-05-05
An inimitable proprotein convertase subtilisin kexin-9 (PCSK9) cleavage site VFAQ on Spike protein along with furin cleavage site makes SARS-CoV-2 unique
Pandya, M. D., Shukla, D., Shah, S., Das, K., Dave, S., Das, J.
10.1101/2023.05.04.539453 — Posted: 2023-05-05
Adsorption of respiratory syncytial virus (RSV), rhinovirus, SARS-CoV-2, and F+ bacteriophage MS2 RNA onto wastewater solids from raw wastewater
Roldan-Hernandez, L., Boehm, A.
10.1101/2023.05.04.539429 — Posted: 2023-05-05
UDCA May Promote COVID-19 Recovery: A Cohort Study with AI-Aided Analysis
Yu, Y., Yu, G., Han, L.-Y., Li, J., Zhang, Z.-L., Liu, T.-S., Li, M.-F., Zhan, D.-C., Tang, S.-Q., Zhou, Z.-H., Wang, G.-J.
10.1101/2023.05.02.23289410 — Posted: 2023-05-04

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).